Breaking News

Today Show Full Stories X To view all stories in expanded form, please subscribe. Get Free Trial Send Info
RHHBY Roche $0.00 (0.00%) 04:55 12/11/18 12/11 04:55 12/11/18 04:55 Conference/Events	Roche management to meet with Jefferies » Meeting to be held in Los… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	11 Dec 13 Dec 24 Dec 18 Mar

Yesterday
GILD Gilead $67.57 -0.6 (-0.88%) , RHHBY Roche $0.00 (0.00%) 10:10 12/10/18 12/10 10:10 12/10/18 10:10 OnTheFly	Gilead’s hiring of Roche veteran as new CEO seen as a positive » Commenting on the news… Open Full Text GILD Gilead $67.57 -0.6 (-0.88%) RHHBY Roche $0.00 (0.00%) 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	11 Dec 24 Dec 18 Mar
RHHBY Roche $0.00 (0.00%) 05:24 12/10/18 12/10 05:24 12/10/18 05:24 Hot Stocks	Roche CEO Daniel O'Day to step down, Genentech CEO William Anderson to succeed » Roche (RHHBY) announced… Roche (RHHBY) announced that Daniel O'Day, CEO Roche Pharmaceuticals and member of the Corporate Executive Committee, will be stepping down from his role as of December 31, 2018. Until the end of February 2019 and prior to assuming new responsibilities outside of Roche, he will provide his support to ensure a smooth transition of activities. William Anderson, currently CEO of Genentech, will be appointed CEO Roche Pharmaceuticals effective January 1, 2019. He will be based in Basel, report to Severin Schwan, Roche Group CEO and become a member of the Corporate Executive Committee. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	11 Dec 24 Dec 18 Mar
GILD Gilead $68.17 -2.01 (-2.86%) , RHHBY Roche $0.00 (0.00%) 05:21 12/10/18 12/10 05:21 12/10/18 05:21 Hot Stocks	Gilead appoints Roche CEO Daniel O'Day as CEO, chairman » Gilead Sciences announced… Gilead Sciences announced that its board has named Daniel O'Day chairman of the board and CEO, effective March 1, 2019. O'Day is currently the CEO of Roche Pharmaceuticals (RHHBY). He has held the position since 2012, and prior to that led Roche Diagnostics. The Board has also appointed Gregg Alton as interim CEO for the period of January 1, 2019 until O'Day's start date of March 1, 2019. Alton has held a number of executive positions at Gilead over the past 20 years, with experience in legal, medical affairs, policy and commercial. He previously served as general counsel and in August of this year, was appointed Chief Patient Officer. GILD Gilead $68.17 -2.01 (-2.86%) RHHBY Roche $0.00 (0.00%) 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	11 Dec 24 Dec 18 Mar

Sunday
GILD Gilead $68.17 -2.01 (-2.86%) , RHHBY Roche $0.00 (0.00%) 20:38 12/09/18 12/09 20:38 12/09/18 20:38 Periodicals	Gilead to hire Roche's Daniel O'Day as next CEO, WSJ reports » Gilead Sciences (GILD)… Gilead Sciences (GILD) plans to hire Daniel O'Day as its next CEO as it looks to revive sales and recover from a disappointing deal, Jonathan Rockoff and Joseph Walker of Wall Street Journal report, citing people familiar with the matter. Day comes from Roche (RHHBY) where he most recently ran the company's pharmaceuticals group, sources tell the Journal. An announcement could come as soon as Monday, Rockoff and Walker say. Reference Link GILD Gilead $68.17 -2.01 (-2.86%) RHHBY Roche $0.00 (0.00%) 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	11 Dec 24 Dec 18 Mar

Saturday
AMGN Amgen $191.43 -7.55 (-3.79%) , AZN AstraZeneca $38.18 -0.69 (-1.78%) … 04:55 12/08/18 12/08 04:55 12/08/18 04:55 Conference/Events	San Antonio Breast Cancer to hold a symposium » San Antonio Breast Cancer… San Antonio Breast Cancer Symposium 2018 will be held in San Antonio, TX on December 3-8. AMGN Amgen $191.43 -7.55 (-3.79%) AZN AstraZeneca $38.18 -0.69 (-1.78%) CELG Celgene $70.07 -2.76 (-3.79%) ESALY Eisai $0.00 (0.00%) GHDX Genomic Health $72.93 -2.66 (-3.52%) IMMU Immunomedics $17.55 -1.43 (-7.53%) KTWO K2M Group $0.00 (0.00%) LLY Eli Lilly $113.63 -2.175 (-1.88%) MGNX MacroGenics $16.44 -0.15 (-0.90%) MDT Medtronic $94.26 -1.96 (-2.04%) MRK Merck $76.71 -1.64 (-2.09%) MYGN Myriad Genetics $31.53 -0.59 (-1.84%) TSRO Tesaro $73.87 0.1 (0.14%) SPPI Spectrum $12.35 -0.42 (-3.29%) SNDX Syndax $4.78 0.02 (0.42%) SGEN Seattle Genetics $60.01 -1.99 (-3.21%) RHHBY Roche $0.00 (0.00%) RDUS Radius Health $15.80 -0.49 (-3.01%) PBYI Puma Biotechnology $23.17 -0.59 (-2.48%) PFE Pfizer $43.92 -1.05 (-2.33%) NVS Novartis $87.16 -1.91 (-2.14%) NSTG NanoString $17.11 -0.59 (-3.33%) 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	10 Dec 10 Dec 11 Dec 11 Dec 14 Dec 18 Dec 19 Dec 24 Dec 11 Jan 16 Jan 18 Jan 16 Feb 18 Mar

Friday
RHHBY Roche $0.00 (0.00%) 10:59 12/07/18 12/07 10:59 12/07/18 10:59 Conference/Events	Roche management to meet with Jefferies » Meeting to be held in Los… Meeting to be held in Los Angeles on December 11 hosted by Jefferies. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	11 Dec 24 Dec 18 Mar
AMGN Amgen $198.98 1.22 (0.62%) , AZN AstraZeneca $38.87 -1 (-2.51%) … 04:55 12/07/18 12/07 04:55 12/07/18 04:55 Conference/Events	San Antonio Breast Cancer to hold a symposium » San Antonio Breast Cancer… San Antonio Breast Cancer Symposium 2018 will be held in San Antonio, TX on December 3-8. AMGN Amgen $198.98 1.22 (0.62%) AZN AstraZeneca $38.87 -1 (-2.51%) CELG Celgene $72.83 0.34 (0.47%) ESALY Eisai $0.00 (0.00%) GHDX Genomic Health $75.59 1.77 (2.40%) IMMU Immunomedics $18.98 0.16 (0.85%) KTWO K2M Group $0.00 (0.00%) LLY Eli Lilly $115.80 -0.77 (-0.66%) MGNX MacroGenics $16.59 0.96 (6.14%) MDT Medtronic $96.22 -0.33 (-0.34%) MRK Merck $78.35 0.07 (0.09%) MYGN Myriad Genetics $32.12 0.56 (1.77%) TSRO Tesaro $73.77 0.03 (0.04%) SPPI Spectrum $12.77 -0.3 (-2.30%) SNDX Syndax $4.76 -0.2 (-4.03%) SGEN Seattle Genetics $62.00 0.94 (1.54%) RHHBY Roche $0.00 (0.00%) RDUS Radius Health $16.29 0.25 (1.56%) PBYI Puma Biotechnology $23.76 0.09 (0.38%) PFE Pfizer $44.97 -0.21 (-0.46%) NVS Novartis $89.07 -1.69 (-1.86%) NSTG NanoString $17.70 0.8 (4.73%) 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	07 Dec 10 Dec 10 Dec 11 Dec 14 Dec 18 Dec 19 Dec 24 Dec 11 Jan 16 Jan 18 Jan 16 Feb 18 Mar

Thursday
RHHBY Roche $0.00 (0.00%) 17:16 12/06/18 12/06 17:16 12/06/18 17:16 Hot Stocks	FDA approves Genentech's Tecentriq regimen for treatment of NSCLC » Genentech, a member of… Genentech, a member of the Roche Group, announced that the U.S. FDA approved Tecentriq, in combination with Avastin, paclitaxel and carboplatin, for the initial treatment of people with metastatic non-squamous non-small cell lung cancer with no EGFR or ALK genomic tumor aberrations. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	24 Dec 18 Mar
AMGN Amgen $197.76 -5.17 (-2.55%) , AZN AstraZeneca $39.87 0.32 (0.81%) … 04:55 12/06/18 12/06 04:55 12/06/18 04:55 Conference/Events	San Antonio Breast Cancer to hold a symposium » San Antonio Breast Cancer… San Antonio Breast Cancer Symposium 2018 will be held in San Antonio, TX on December 3-8. AMGN Amgen $197.76 -5.17 (-2.55%) AZN AstraZeneca $39.87 0.32 (0.81%) CELG Celgene $72.49 -0.92 (-1.25%) ESALY Eisai $0.00 (0.00%) GHDX Genomic Health $73.82 -4.22 (-5.41%) IMMU Immunomedics $18.82 -1.75 (-8.51%) KTWO K2M Group $0.00 (0.00%) LLY Eli Lilly $116.57 -1.93 (-1.63%) MGNX MacroGenics $15.63 -1.37 (-8.06%) MDT Medtronic $96.55 -2.18 (-2.21%) MRK Merck $78.28 -0.94 (-1.19%) MYGN Myriad Genetics $31.56 -0.96 (-2.95%) TSRO Tesaro $73.74 0.23 (0.31%) SPPI Spectrum $13.07 -1.29 (-8.98%) SNDX Syndax $4.96 -0.51 (-9.32%) SGEN Seattle Genetics $61.06 -2.88 (-4.50%) RHHBY Roche $0.00 (0.00%) RDUS Radius Health $16.04 -1.22 (-7.07%) PBYI Puma Biotechnology $23.67 -0.11 (-0.46%) PFE Pfizer $45.18 -0.815 (-1.77%) NVS Novartis $90.76 -0.79 (-0.86%) NSTG NanoString $16.90 -0.35 (-2.03%) 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	06 Dec 10 Dec 10 Dec 11 Dec 14 Dec 18 Dec 19 Dec 24 Dec 11 Jan 16 Jan 18 Jan 16 Feb 18 Mar

Get Full Fly Access

Breaking market intelligence sent straight to you: Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.

Up-to-date information on important industry events: Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.

News focused on the companies in your portfolio: Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.

14 Day Free Trial